Vanessa Carle
Secretary · Lexaria Bioscience Corp.
IndividualBuying only
- 2025
- Jul 29, 2025
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who have reported open-market trades at the same companies as Vanessa Carle. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Richard Christopher - $132K in LEXX purchases and sales on record
- Christopher Bunka - $25K in LEXX purchases and sales on record
- John Martin Docherty - $5K in LEXX purchases and sales on record
- William Edward McKechnie - $5K in LEXX purchases and sales on record
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Vanessa Carle?
Vanessa Carle is a corporate insider, tracked as Secretary of Lexaria Bioscience Corp. (LEXX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Vanessa Carle last file a Form 4?
The only primary Form 4 on record is dated 29 July 2025.
Has Vanessa Carle been buying or selling stock?
Recorded transactions: 1 open-market purchase ($682) and 0 open-market sales across all tracked filings.
